Skip to main content
Zydus Lifesciences Limited (NSE:ZYDUSLIFE)
India flag India · Delayed Price · Currency is INR
923.10
+14.25 (1.57%)
Mar 10, 2026, 3:30 PM IST

Zydus Lifesciences Revenue

Zydus Lifesciences had revenue of 68.65B INR in the quarter ending December 31, 2025, with 30.28% growth. This brings the company's revenue in the last twelve months to 260.89B, up 17.27% year-over-year. In the fiscal year ending March 31, 2025, Zydus Lifesciences had annual revenue of 232.42B with 18.90% growth.

Revenue (ttm)
260.89B
Revenue Growth
+17.27%
P/S Ratio
3.51
Revenue / Employee
9.35M
Employees
27,917
Market Cap
914.52B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 2025232.42B36.94B18.90%
Mar 31, 2024195.47B23.10B13.40%
Mar 31, 2023172.37B21.28B14.08%
Mar 31, 2022151.10B7.06B4.90%
Mar 31, 2021144.04B1.50B1.06%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Mankind Pharma 139.14B
Cipla 279.67B
Aurobindo Pharma 331.82B
Alkem Laboratories 142.53B
Glenmark Pharmaceuticals 165.10B
Laurus Labs 67.22B
Divi's Laboratories 103.14B
Ipca Laboratories 95.06B
Revenue Rankings

Zydus Lifesciences News

More News